posted on 2014-10-07, 03:17authored byCarolin Reischauer, Johannes Malte Froehlich, Miklos Pless, Christoph Andreas Binkert, Dow-Mu Koh, Andreas Gutzeit
* The patient deceased prior to tumor progression due to causes unrelated to lung cancer.
Specific therapy, length of progression-free interval, and lesion cross section size on CT before and after treatment for each patient.